Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Weekly GLP-1 Receptor Agonists in Non-Diabetic Obese Individuals
NCT07834398Phase 3Completed
- Sponsor
- Zagazig University
- Start
- Nov 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 3 trial of dulaglutide biosimilar 14028 injection, semaglutide, tirzepatide in obesity, sponsored by Zagazig University. Started Nov 2025; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07834398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07834398.